Valuation: Zai Lab Limited

Market Cap 2.91B 2.51B 2.36B 2.15B 4.04B 278B 4.1B 27.65B 10.81B 139B 10.92B 10.68B 463B P/E 2026 *
-11.4x
P/E 2027 * -12x
Enterprise Value 2.45B 2.12B 1.99B 1.81B 3.4B 234B 3.46B 23.3B 9.11B 117B 9.2B 9B 390B EV / Sales 2026 *
5.8x
EV / Sales 2027 * 4.44x
Free-Float
94.05%
Yield 2026 *
-
Yield 2027 * -
1 day-2.18%
1 week+11.06%
Current month+41.76%
1 month+24.82%
3 months+25.79%
6 months+29.31%
Current year+46.83%
1 week 23.54
Extreme 23.54
26.66
1 month 17.92
Extreme 17.92
26.66
Current year 15.96
Extreme 15.96
26.66
1 year 15.96
Extreme 15.96
36.77
3 years 13.48
Extreme 13.48
44.34
5 years 13.48
Extreme 13.48
152.82
10 years 13.48
Extreme 13.48
193.54
Manager TitleAgeSince
Chief Executive Officer 61 01/04/2014
Director of Finance/CFO 58 07/07/2023
President 62 01/12/2022
Director TitleAgeSince
Chairman 61 01/04/2014
Director/Board Member 83 01/01/2017
Director/Board Member 75 01/01/2017
Date Insider Type Main position Quantity % Market Cap.
8/12/26 A Sell

Director

-8,506 0.0007%
8/11/26 A Sell

Chief Financial Officer

-619 0.0001%
7/2/26 A Other

Chief Executive Officer

-43,480 0.0038%
Change 5-day change 1-year change 3-year change Capi.($)
-0.50%+11.06%-27.51%+7.29% 2.91B
-0.31%+2.44%+38.43%+0.77% 80.23B
-1.02%-0.51%-2.54%+28.91% 50.64B
+1.46%-4.31%+10.21%+164.55% 46.87B
-1.39%+0.10%-50.39%-50.07% 46.34B
-0.39%+0.91%+51.39%-20.90% 31B
-0.52%+7.01%+125.98%-35.99% 25.28B
-0.30%-0.33%+38.24%+85.63% 24.36B
+1.65%-2.00%-6.43%+191.59% 20.81B
+2.70%+0.80%+61.57%+118.69% 16.08B
Average +0.03%+1.42%+23.90%+49.05% 34.45B
Weighted average by Cap. -0.05%+0.62%+22.01%+38.79%

Financials

2026 *2027 *
Net sales 423M 365M 343M 312M 587M 40.41B 596M 4.02B 1.57B 20.24B 1.59B 1.55B 67.25B 569M 491M 462M 420M 789M 54.4B 802M 5.41B 2.12B 27.24B 2.14B 2.09B 90.52B
Net income -245M -212M -199M -181M -340M -23.43B -346M -2.33B -911M -11.73B -920M -900M -38.99B -187M -161M -152M -138M -259M -17.87B -264M -1.78B -695M -8.95B -702M -687M -29.74B
Net Debt -458M -395M -371M -338M -635M -43.76B -646M -4.35B -1.7B -21.91B -1.72B -1.68B -72.83B -381M -329M -309M -281M -528M -36.41B -537M -3.62B -1.42B -18.24B -1.43B -1.4B -60.6B
Logo Zai Lab Limited
Zai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets.
Employees
1,784
Date Price Change Volume
14/08/26 $25.90 -0.50% 1,234,060
13/08/26 $26.03 +2.12% 1,042,216
12/08/26 $25.49 -1.96% 2,182,416
11/08/26 $26.00 +10.31% 3,809,572
10/08/26 $23.57 +1.07% 1,698,221
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
25.90USD
Average target price
32.18USD
Spread / Average Target
+24.25%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ZLAB Stock